322 related articles for article (PubMed ID: 23847160)
1. Process cost and facility considerations in the selection of primary cell culture clarification technology.
Felo M; Christensen B; Higgins J
Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
[TBL] [Abstract][Full Text] [Related]
2. Design of a filter train for precipitate removal in monoclonal antibody downstream processing.
Kandula S; Babu S; Jin M; Shukla AA
Biotechnol Appl Biochem; 2009 Oct; 54(3):149-55. PubMed ID: 19656082
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a single-use disk stack centrifuge for improved efficiency and sustainability at 1000 L GMP manufacturing scale.
Walker J; Lam Y; Loman A; Smelko JP; Rohr M
Biotechnol Bioeng; 2023 Nov; 120(11):3347-3356. PubMed ID: 37539666
[TBL] [Abstract][Full Text] [Related]
4. Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters.
Singh N; Pizzelli K; Romero JK; Chrostowski J; Evangelist G; Hamzik J; Soice N; Cheng KS
Biotechnol Bioeng; 2013 Jul; 110(7):1964-72. PubMed ID: 23334838
[TBL] [Abstract][Full Text] [Related]
5. Robust depth filter sizing for centrate clarification.
Lutz H; Chefer K; Felo M; Cacace B; Hove S; Wang B; Blanchard M; Oulundsen G; Piper R; Zhao X
Biotechnol Prog; 2015; 31(6):1542-50. PubMed ID: 26518411
[TBL] [Abstract][Full Text] [Related]
6. Pretreatments for enhancing clarification efficiency of depth filtration during production of monoclonal antibody therapeutics.
Hadpe SR; Mohite V; Alva S; Rathore AS
Biotechnol Prog; 2020 Sep; 36(5):e2996. PubMed ID: 32223061
[TBL] [Abstract][Full Text] [Related]
7. Single-stage chromatographic clarification of Chinese Hamster Ovary cell harvest reduces cost of protein production.
O'Mara B; Singh NK; Menendez A; Tipton B; Vail A; Voloshin A; Buechler Y; Anderson SM
Biotechnol Prog; 2023 Mar; 39(2):e3323. PubMed ID: 36598038
[TBL] [Abstract][Full Text] [Related]
8. A scale-down mimic for mapping the process performance of centrifugation, depth and sterile filtration.
Joseph A; Kenty B; Mollet M; Hwang K; Rose S; Goldrick S; Bender J; Farid SS; Titchener-Hooker N
Biotechnol Bioeng; 2016 Sep; 113(9):1934-41. PubMed ID: 26927621
[TBL] [Abstract][Full Text] [Related]
9. Ultra scale-down approaches for clarification of mammalian cell culture broths in disc-stack centrifuges.
Zaman F; Allan CM; Ho SV
Biotechnol Prog; 2009; 25(6):1709-16. PubMed ID: 19768799
[TBL] [Abstract][Full Text] [Related]
10. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
Dizon-Maspat J; Bourret J; D'Agostini A; Li F
Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
[TBL] [Abstract][Full Text] [Related]
11. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
Xenopoulos A
J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
[TBL] [Abstract][Full Text] [Related]
12. The effect of antiapoptosis genes on clarification performance.
Potty AS; Xenopoulos A; Patel S; Prentice H; Dileo A
Biotechnol Prog; 2014; 30(1):100-7. PubMed ID: 24124050
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification.
Yigzaw Y; Piper R; Tran M; Shukla AA
Biotechnol Prog; 2006; 22(1):288-96. PubMed ID: 16454522
[TBL] [Abstract][Full Text] [Related]
14. Clarification of vaccines: An overview of filter based technology trends and best practices.
Besnard L; Fabre V; Fettig M; Gousseinov E; Kawakami Y; Laroudie N; Scanlan C; Pattnaik P
Biotechnol Adv; 2016; 34(1):1-13. PubMed ID: 26657051
[TBL] [Abstract][Full Text] [Related]
15. Integrated economic and experimental framework for screening of primary recovery technologies for high cell density CHO cultures.
Popova D; Stonier A; Pain D; Titchener-Hooker NJ; Farid SS
Biotechnol J; 2016 Jul; 11(7):899-909. PubMed ID: 27067803
[TBL] [Abstract][Full Text] [Related]
16. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
17. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.
Pollock J; Bolton G; Coffman J; Ho SV; Bracewell DG; Farid SS
J Chromatogr A; 2013 Apr; 1284():17-27. PubMed ID: 23453463
[TBL] [Abstract][Full Text] [Related]
18. Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator.
Hong JS; Azer N; Agarabi C; Fratz-Berilla EJ
J Vis Exp; 2020 May; (159):. PubMed ID: 32478745
[TBL] [Abstract][Full Text] [Related]
19. Case Study: an accelerated 8-day monoclonal antibody production process based on high seeding densities.
Padawer I; Ling WL; Bai Y
Biotechnol Prog; 2013; 29(3):829-32. PubMed ID: 23596148
[TBL] [Abstract][Full Text] [Related]
20. Decisional tool to assess current and future process robustness in an antibody purification facility.
Stonier A; Simaria AS; Smith M; Farid SS
Biotechnol Prog; 2012 Jul; 28(4):1019-28. PubMed ID: 22641562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
